BCAT1 and colorectal cancer: Differently methylated regions within markers such as BCAT1, SEPT9 and IKZF1 have previously been shown to have ignorable levels of methylation in WBCs and high levels in colonoscopy-confirmed patients with colorectal cancer [34].